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INTRODUCTION
Coordination chemistry of substituted hydrazone ligands
is well known since past few decades due to their structural
flexibility, chelating abilities, diverse bonding modes towards
transition metal ions and numerous biological applications
[1-4]. The presence of azomethine group in Schiff’s bases is
known for antifungal [5], antibacterial [6], antitubercular [7],
antitumor [8] and anticancer [9] properties. Oxygen containing
heterocyclic compound like dehydroacetic acid (DHA) is well
known chelating agent with excellent insecticidal and herbi-
cidal activities [10,11]. The copper complex of hydrazone based
ligand prepared by the condensation of dehydroacetic acid
with 1,2-diaminopropane displays electro catalytic behaviour
towards electro reduction of aryl and alkyl halides [12]. Transi-
tion metal complexes of hydrazone are reported for excellent
catalytic activities in different chemical reactions such as poly-
merization of ethylene [13], epoxidation of olefins [14,15] and
transamination of carboxamides with amines [16].
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Different transition metal complexes were synthesized from novel 3-bromo-2-[1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-
yl)ethylidene]hydrazide ligand (H2L) and characterized by spectral techniques. The synthesized ligand was found to act mono as well as
di deprotonated (OH, NH) manner and stoichiometry of the ligand to metal ions was confirmed to be 1:1 in case of complex using metal
chloride salts, whereas 1:2 in case of metal(II) complexes using metal acetate(II) salt. Structures of metal complexes were confirmed by
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octahedral geometry and those of Cu(II), Zn(II) showed square planner and tetrahedral geometry around metal ion respectively. Furthermore
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In continuation of our present work in the synthesis and
biological evaluation of metal complexes [17-19]; in the present
article we report synthesis of dehydroacetic acid (DHA) based
tridentate 3-bromo-2-[1-(4-hydroxy-6-methyl-2-oxo-2H-
pyran-3yl)ethylidene]hydrazide (H2L) ligand and its transition
metal complexes. H2L was synthesized by the condensation
of dehydroacetic acid (DHA) and 3-bromobenzhydrazide.
Synthesized ligand was characterized by different spectroscopic
techniques. The synthesized ligand and its complexes were
furthermore screened for antimicrobial activity.
EXPERIMENTAL
All the purchased chemicals were analytical grade and
used without further purification. Solvents were purified and
dried according to literature method [20]. Dehydroacetic acid
(DHA) and ethyl-3-bromo benzoate were Alfa Aesar and Spec-
trochem made respectively. Metal salts were SD Fine made &
used without further purification.
Synthesis of 3-bromobenzhydrazide (3a): A mixture of
ethyl-3-bromobenzoate (1) (2 mmol) and hydrazine hydrate
(2) (80 %) (3 mmol) was refluxed for 7 h. The progress of reaction
was monitored by TLC using 20 % EtOAc:n-hexane. After
completion of reaction; the reaction mixture was cooled, the
precipitated solid was filtered off, recrystallized from ethanol
and confirmed by 1H NMR as the pure hydrazide (3a) (Scheme-
I). Yield = 80 %, Colour-White, solid, m.p. 158 °C; 1H NMR
(200 MHz, DMSO-d6) ppm 4.54 (br., s., 2 H, NH2), 7.37 - 7.47
(dd, J = 8.5, 8 Hz, 1H), 7.67 - 7.86 (m, 2 H), 7.98 (dd, J = 1.83,
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Scheme-I: Synthesis of 3-bromobenzhydrazide
Synthesis of 3-bromo-2-[1-(4-hydroxy-6-methyl-2-oxo-
2H-pyran-3-yl)ethylidene]-hydrazide (H2L) (5a): 3-Bromo-
benzhydrazide (3a) (1 g; 0.004 mol) was added to a solution
of dehydroacetic acid (DHA) (4) (0.785 g; 0.004 mol) in
ethanol (15 mL) and the mixture was refluxed for 1.5 h. The
pale yellow precipitate obtained was filtered off; washed with
ethanol and recrystallized from ethanol as the pure ligand
H2L.Yield-85 %, Colour-White, m.p. 278 °C (Scheme-II).
Spectral data of ligand (H2L): IR (KBr, νmax, cm-1):
3134.33 (NH), 1662.64 (pyranone C=O), 1600 (C=O); 1H
NMR (500 MHz, DMSO-d6) δ ppm 2.13 (s, 3H, CH3), 2.63 (s,






















Scheme-II: Synthesis of ligand (H2L)
10,7.5 Hz, 1H, Ar-H), 7.86-7.92 (m, 2H, Ar-H), 8.08-8.09 (dd,
J = 1.8,1.5 Hz, 1H, Ar-H), 11.73 (br., s, 1H, CONH), 16.00
(br., s, 1H, enolic OH of DHA); 13C NMR (500 MHz, DMSO-
d6): δ ppm-17.07 (s, azomethine- CH3), 19.30 (s, DHA-CH3),
94.93 (quat, DHA), 105.91 (s, DHA),121.80 (quat, Ar), 127.08
(s, Ar), 130.45 (s, Ar), 133.68 (quat, Ar), 135.21 (s, Ar) 162.32
(quat, azomethine), 163.34 (quat, C=O), 171.28 (quat, DHA),
182.00 (quat, 2C, DHA enolic); LC-MS: m/z (%) 365.0 (M+H),
367 (M+2).
General procedure for the synthesis of metal complexes
(6a-g): Methanolic solution of corresponding metal salt (chloride
or acetate) was added to the methanolic solution of ligand
(H2L). A slightly basic pH of the mixture for 1:1 ratio of metal
to ligand was maintained by adding alcoholic ammonia and
the contents were refluxed for 6 h. The reaction was confirmed
to be complete after the disappearance of starting materials
on TLC. The products were filtered off, washed with hot
methanol thrice (Scheme-III). The physical and analytical data
of synthe-sized compounds is mentioned in Table-1.
RESULTS AND DISCUSSION
Infrared spectra: The band at 3514 cm-1 in infrared








































               6a, b, c, d, g.
M= Mn (II), Co (II), Ni (II), Cu (II), Cd (II).
6e,  f .
M= Cu (II), Zn (II).
Scheme-III: Synthesis of metal complexes (6a-g)
TABLE-1 
PHYSICAL AND ANALYTICAL DATA OF THE SYNTHESIZED COMPOUNDS 
Elemental analysis (%): Found (Calcd.) 
Compd. No. Compound m.f. (F.W.) m.p. (°C) Colour 
C H N M 
5a Ligand (H2L) C15H13N2O4Br 
(364.00) 



















6b [Co(HL)2] C30H24N4O8Br2Co 
(385.00) 








6c [Ni (HL)2] C30H24N4O8Br2Ni 
(384.00) 








6d [Cu(HL)2] C30H24N4O8Br2Cu 
(788.92) 








6e [Cu(L)(H2O)] C15H13N2O5BrCu 
(442.93) 








6f [Zn(L)(H2O)] C15H13N2O5BrZn 
(443.92) 








6g [Cd(HL)2] C30H24N4O8Br2Cd 
(839.89) 
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disappearing in all metal complexes clearly indicates the parti-
cipation of pyranone oxygen in coordination with the metal
ions by deprotonation [21]. The strong band for azomethine
group at 1595 cm-1 in ligand was shifted to lower side in the
IR spectrum of all metal complexes, indicating the coordination
of azomethine nitrogen to metal ion. In free ligand band at
1662 cm-1 arises due to C=O stretch of pyranone ring in all metal
complexes which indicates its non-participation in coordi-
nation. Spectral data suggests that the ligand has coordinated
through azomethine nitrogen, amide carbonyl oxygen and oxygen
of pyranone ring by deprotonation in all metal complexes, but
in 2:1 ratio of ligand to metal the amide C=O coordinated
without deprotonation.
The band for O-H stretch at 3514 cm-1 in free ligand dis-
appears in [Zn(L)(H2O)]. An additional band appearing at 3522
cm-1 is due to coordination of water molecule to metal ion.
Azomethine nitrogen band at 1595 cm-1 was shifted to lower
region at 1573 cm-1 indicating the coordination of azomethine
nitrogen to metal ion. The absence of band at 3134 cm-1 for
amide N-H stretch in complex indicates the coordination of
amide oxygen through enolate by deprotonation. Thus, from
IR data the ligand acts as monobasic for [Mn(HL)2], [Co(HL)2],
[Cu(HL)2], [Ni(HL)2] complexes and dibasic for [Zn(L)(H2O)],
[Cu(L)(H2O)] complexes.
NMR analysis: Two signals observed at 16.00 and 11.73
δ ppm correspond to enolic OH and amide NH respectively in
the 1H NMR spectrum of the free ligand. These signals were
disappeared in 1H NMR spectrum of [Zn(L)H2O)] complex
indicating the coordination of these two sites via deprotonation.
The aromatic protons in the range of 7.902-8.092 δ ppm reso-
nating as multiplet in 1H NMR spectrum of non-coordinated
ligand have shifted slightly to downfield in the range 8.05-
8.16 δ ppm of metal complex. Two CH3 protons were observed
as singlets at 2.136 and 2.632 δ ppm in free ligand have moved
to 2.06 and 2.55 δ ppm respectively after formation of the
complex [22].
In 13C NMR spectrum of free ligand signals observed at
182.00 and 17.07 ppm corresponds to 2C (quat.) (DHA) and
azomethine(s) CH3 respectively were shifted to 178.86 and 19.19
δ ppm in the spectrum of [Zn(L)H2O)] complex, indicating
the coordination of ligand-OH via deprotonation. The azome-
thine carbon has moved to downfield in the spectrum of complex
indicating the participation of azomethine nitrogen in comp-
lexation with metal ion. The two aromatic quartets for carbons
observed at 121.80 and 133.68 δ ppm in the ligand were shifted
to downfield at 121.44 and 132.21 δ ppm, which also confirms
the coordination of amide NH via deprotonation.
Thermal analysis: Thermal study of metal complexes
gives an idea about the presence or absence of lattice or coordi-
nated held solvent molecules and is useful to confirm their
composition and thermal stability. The thermal analysis was
performed under nitrogen atmosphere in the temperature range
of 25-800 °C at a heating rate of 10 °C per min.
The thermogram of [Zn(L)H2O)] gives two peaks as shown
in Fig. 1. At about 260 °C, most of the organic material along
with water has been evaporated. Whereas at 450 °C, the metal
was converted to its oxide which is not decomposed upon






























Fig. 1. TGA-DTA analysis of [Zn(L)(H2O)]
Electronic spectra: Electronic spectra of the synthesized
transition metal complexes were recorded in DMSO solvent
at room temperature. The complexes exhibited two bands in
the range 349-375 nm which were assigned for charge transfer
spectra observed after complex formation [23]. This indicated
the coordination of azomethine nitrogen to metal ions and
another band in the range of 280-290 nm corresponding to
the π→π* transition (Fig. 2).
Antimicrobial study: Antimicrobial activity of the synthe-
sized compounds was evaluated against one bacterial Strepto-
coccus aureus and two fungal species Aspergillums niger and
Alternaria alternata using petri plate method at 250 ppm con-
centration in DMSO solvent and compared with the standard
antibiotics - streptomycin and carbendazim respectively. The
petri plate (stains) containing 30 mL nutrient agar and potato
dextrose agar (PDA) medium for bacteria and fungi were
incubated for 20-24 h and 24-48 h respectively at 37 °C and
the zones of inhibition were measured in terms of mm. The
results were compared with the standard antibiotics. The metal
complexes showed more inhibitory effects than the non-coor-
dinated ligand against used species under identical condition.
From Table-2, antibacterial activity of ligand and the synthe-
sized metal complexes was found to be less against Strepto-
coccus aureus as compared with the standard drug streptomycin.
However Cd(II) and Mn(II) complexes exhibited excellent
activity against Alternaria alternata than the standard drug
carbenzadim. The remaining compounds showed lesser
activity. On the other hand; Cd (II) complex exhibited excellent
activity against Aspergillums niger even more than the standard
drug carbendazim.
Conclusion
In conclusion, a new 3-bromo-2-[1-(4-hydroxy-6-methyl-
2-oxo-2H-pyran-3-yl)ethylidene] hydrazide ligand and its
transition metal complexes were synthesized and characterized.
Antimicrobial activity of the synthesized compounds revealed
that the Cd(II) complex shows excellent activity against fungal
species and Mn(II) complex shows moderate to good activity
against A. niger and Alternaria alternata, respectively. However,
antibacterial activity of all the screened compounds was found
to be less in comparison with the standard.
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TABLE-2 
ANTIMICROBIAL ACTIVITY OF THE SYNTHESIZED  
LIGANDS AND ITS TRANSITION METAL COMPLEXES 
Mean zone of inhibition diameter in mm 




A. niger A. alternata S. aureus 
5a Ligand (H2L) 15 5 15 
6a [Mn(HL)2] 22 35 15 
6b [Co(HL)2] 20 27 17 
6c [Ni (HL)2] 15 5 11 
6d [Cu(HL)2] 5 20 12 
6e [Cu(L)(H2O)] 20 35 12 
6f [Zn(L)(H2O)] 20 22 20 
6g [Cd(HL)2] 30 40 12 
Standard (Carbendazim) 24 26 – 
Standard (Streptomycin) – – 40 
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Fig. 2. Electronic spectra of the synthesized metal complexes
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INTRODUCTION
The important feature of Green Chemistry is removal of
harmful solvents or use of greener solvents such as to replace
hazardous solvents with comparatively mild solvents like alcohol,
surfactant and ionic liquids in chemical processes. Ethyl alcohol
is the naturally benign, clean, economical solvent. Today major
universal problem is pollution, so the most interesting chall-
enge in organic synthesis for scientist community is to design
easy and eco-friendly methodology such as multi-component
reactions (MCRs). The MCRs has been attracting attention of
numerous chemists because it is a powerful technique for
synthesis of derivatives with biological activity and pharmaceu-
tical properties [1]. To develop clean, easy and eco-friendly
method for the synthesis of organic moiety with significant
biological activity is the further most important objective in
synthetic organic chemistry and is also helpful in research area
of green or sustainable chemistry [2].
The natural products are rich source of active ingredients
having wide range of medicinal application. The chromene is
important heterocyclic compound showing great application
in medicinal drug discovery. The chromene is a heterocyclic
ring system containing 2H-chromen-2-one ring fused to pyran
ring. Chromene forms the basic framework which is widely
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found in natural products like tocopherols, flavonoids, vitamin
E, warfarin, chalcone and luteic acid. Chromene derivatives
are structural moiety commonly found in most of the alkaloids
with manifesting diverse biological activities [3,4]. The dihydro-
pyrano[c]chromenes derivatives has fascinated attention of an
important class of heterocyclic chemistry having useful pharma-
cological and biological activity such as analgesic [5], anti-
HIV [6], anticancer [7], antituberculosis agents [8], anticoagulant
[9], antibacterial [10], anti-Alzheimer [11], antimalarial [5],
antimicrobials [8], antifungal [12], molluscidal [13], acetyl
cholinesterase inhibitor [14] and anti-inflammatory [15]. The
derivatives of dihydropyrano[2,3-c]chromene can also be employed
as cosmetic pigment and utilized as potential biodegradable
agrochemical [16].
The synthesis of various 3,4-dihydropyrano[c]chromene
derivatives have been reported using catalysts such as K2CO3
[17],tetrabuthylammonium bromide (TBAB) [18], s-proline
[19], nano Al2O3 [20], cesium carbonate [21], thiourea dioxide
[22], [DBU][Ac] [23], nano-structured ZnO [24], LSMO [25],
HEAA [26], SuSa [27], [Bmim]HSO4 [28], Amberlite A21
[29], Ru(II) [30], Mo132 [31], ammonium acetate [32], DBU
[33], piperidine [34], NaBr [35], ([DMAP-PEG1000-DIL]
[BF4]) [36] and ionic liquid [37].
EXPERIMENTAL
The solvents, starting material and catalyst were purchased
from S.D. Fine Chemicals, Spectrochem and Sigma Aldrich
with high purity and used without further purification. All the
materials were of commercial grade. Melting points of synthe-
sized derivatives were found out using open capillaries by visual
melting point instrument. The FT-IR spectra recorded using
KBr on Perkin-Elmer FT-IR spectrometer 65. The 1H NMR
spectras were recorded on Bruker Advance spectrometer an
400 MHz in CDCl3 as a solvent at 295 K and chemical shift
record in δ (ppm) using TMS (tetramethylsilane) as an internal
standard. The reactions progresses was monitored by TLC.
The experiments under microwave irradiation were carried out
in 700 W and 2450 MHz frequency model made by RAGA's
Scientific Microwave Synthesis System Pvt. Ltd., Pune, India.
General Procedure for the synthesis of 2-amino-5-oxo-
4,5-dihydropyrano(3,2-c)chromene-3-carbonitriles (3a-p)
Conventional method: A mixture of aryl aldehyde (1.0
mmol), 4-hydroxycoumarin (1.0 mmol), malononitrile (1.1
mmol) and [Emim]OH (0.5 mL) in 50 mL round bottom flask
with 5 mL ethyl alcohol as solvent, was refluxed at 50-60 ºC
for 40-55 min. The reaction progress was observed using TLC
in n-hexane:ethyl acetate (70: 30 v/v) solvent system. After
completion of reaction, the reaction mixture was poured on ice-
cold water, stirred and filtered. The obtained residue was purified
by crystallization from aqueous ethyl alcohol (Scheme-I).
Non-conventional (microwave assisted) method: The
mixture of aryl aldehyde (1.0 mmol), 4-hydroxycoumarin (1.0
mmol), malononitrile (1.1 mmol) and [Emim]OH (0.5 mL).
The reaction mixture was refluxed in microwave oven at 700 W
for 2-4 min. The reaction progress was observed using thin
layer chromatography in n-hexane:ethyl acetate (70:30 v/v)
solvent system. As soon as reaction is completed the reaction
mixture was poured on ice cold water, stirred and filtered. The




chromene-3-carbonitrile (3a): Light yellow colour, m.p. 256-
258 ºC; FT-IR (KBr, νmax, cm-1): 3350, 3250, 2955, 2180, 1690,
1570, 1080. 1H NMR (CDCl3, 400 MHz): δ 4.5 (s, 1H), 7.1-7.4
(m, 5H), 7.6-7.8 (m, 4H), 8.6 (s, 2H). Elemental analysis of
C19H12N2O3 calcd. (found) (%):C, 72.15 (72.10); H, 3.82 (3.82);
N, 8.86 (8.85).
2-Amino-4,5-dihydro-4-(3-nitrophenyl)-5-oxopyrano-
[3,2-c]chromene-3-carbonitrile (3c): Yellow colour solid;
yield 92 %; melting point 257-258 ºC; Recrystallized in
ethanol; FT-IR (KBr, νmax, cm-1): 1045, 1088, 1378, 1527, 1664,
1706, 1717, 2199, 2978, 3349, 3367 (broad); 1H NMR (CDCl3):
δ 5.5 (s, 1H), 7.2 (dd, 1H) 7.4-7.6 (m, 5H), 7.6 (s, 2H), 7.9
(dd, 1H), 8.0 (dd, 1H); MS m/z 384 (M+ + 23).
2-Amino-4,5-dihydro-4-(4-methoxyphenyl)-5-oxo-
pyrano[3,2-c]chromene-3-carbonitrile (3d): Light yellow
color, m.p. 243-244 ºC. FT-IR (KBr, νmax, cm-1): 3185, 2960,
2270, 1670, 1510, 1060.  1H NMR (CDCl3, 400 MHz): δ 3.2
(s, 3H), 4.6 (s, 1H), 7.1-7.4 (m, 4H), 7.5-7.8 (m, 4H), 8.2 (s,
2H). Elemental analysis of C20H14N2O4 calcd. (found) (%):C,
69.36 (69.36); H, 4.07 (4.08); N, 8.09 (8.10).
2-Amino-4,5-dihydro-4-(4-bromophenyl)-5-oxopyrano-
[3,2-c]chromene-3-carbonitrile (3e): Light yellow colour
solid; yield 90 %, m.p. 248-250 ºC; recrystallized in ethanol;
FT-IR (KBr, νmax, cm-1): 1088, 1374, 1485, 1601, 1673, 1707,
2190, 2973, 3308, 3349 (broad). 1H NMR (CDCl3, 400 MHz):
δ 4.6(s, 1H), 7.3 (dd, 1H) 7.4-7.5 (m, 3H), 7.6 (dd, 2H), 7.7
(dd, 1H), 7.9 (dd, 1H), 8.1 (s, 2H); MS m/z 395 (M+ + 1).
Elemental analysis of C19H11N2O3Br calcd. (found) (%):C,
57.74 (57.75); H, 2.81 (2.80); N, 7.09 (7.10).
2-Amino-4,5-dihydro-4-(4-chlorophenyl)-5-oxopyrano-
[3,2-c]chromene-3-carbonitrile (3f): Light yellow color, mp
256-258 ºC; FT-IR (KBr, νmax, cm-1): 3120, 3270, 2945, 2250,
1710, 1610, 1060. 1H NMR (CDCl3, 400 MHz): δ 4.6 (s, 1H),
7.2-7.4 (m, 4H), 7.3-7.5 (m, 4H), 8.7 (s, 2H). Elemental analysis
of C19H11N2O3Cl calcd. (found) (%):C, 65.06 (65.10); H, 3.16
(3.20); N, 7.99 (7.90); O, 13.68 (13.70).
2-Amino-4,5-dihydro-4-(4-fluorophenyl)-5-oxopyrano-
[3,2-c]chromene-3-carbonitrile (3g): Light yellow colour,
m.p. 261-63 ºC; FT-IR (KBr, νmax, cm-1): 3150, 3280, 2955,
2250, 1720, 1620, 1070. 1H NMR (CDCl3, 400 MHz): δ 4.7 (s,


















Scheme-I: Synthetic path of 3,4-Dihydropyrano[c]chromene derivatives
TABLE-1 
COMPARISON OF REACTION CONDITION 
Entry Catalyst Time (min) Condition Yield (%) Ref. 
1 Nano Al2O3 300 90 °C, Reflux 85 [20] 
2 Cesium carbonate 45 Visible light 95 [21] 
3 Water, thiourea 40 Reflux, 70 °C 90-95 [22] 
4 [DBU][Ac] 6-30 Grading 90 [23] 
5 Nano-structured ZnO 150 Reflux 78-91 [24] 
6 [Emim]OH 10-20 Reflux, 50 °C 90-96 Present work 
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 TABLE-3 
[Emim]OH CATALYSED SYNTHESIS OF VARIOUS DIHYDROPYRANO[2,3-c]CHROMENE DERIVATIVES 
Time (min) Yield (%) m.p. (°C) 







method Found Reported 
3a Benzaldehyde 55 3.0 92 90 256-258 255-257 [27,35] 
3b 4-Nitrobenzaldehyde 40 3.0 96 95 245-247 257-262 [27,35] 
3c 3-Nitrobenzaldehyde 40 2.5 92 92 257-258 260-264 [27,35] 
3d 4-Methoxybenzaldehyde 55 3.0 90 88 243-244 241-243 [35,36] 
3e 4-Bromobenzaldehyde 50 3.0 91 90 248-250 225-227 [27,36] 
3f 4-Chlorobenzaldehyde 40 3.0 89 90 256-258 265-267 [35,36] 
3g 4-Fluorobenzaldehyde 40 2.5 93 92 261-63 277-284 [35,36] 
3h 3-Chlorobenzaldehyde 45 3.0 92 90 245-247 243-244 [37] 
3i 4-Methylbenzaldehyde 50 3.5 90 86 280-282 262-265 [35,36] 
3j 4-Hydroxybenzaldehyde 50 4.0 89 88 263-265 262-265 [35,36] 
3k 2,4-Dichlorobenzaldehyde 55 3.0 90 89 260-262 258-266 [35] 
3l 2-Methylbenzaldehyde 45 4.0 88 89 262-264 262-265 [35] 
3m 2-Chlorobenzaldehyde 50 3.0 85 86 263-264 263-264 [37] 
3n Furan-2-carbaldehyde 45 3.0 88 90 223-224 223-224 [27] 
3o 4-(Dimethylamino)benzaldehyde 50 4.0 85 88 225-226 225-226 [36] 
 
analysis of C19H11N2O3F calcd. (found) (%):C, 68.26 (68.24);
H, 3.32 (3.30); N, 8.38 (8.40).
2-Amino-4,5-dihydro-4-(3-chlorophenyl)-5-oxopyrano-
[3,2-c]chromene-3-carbonitrile (3h): Light yellow colour,
m.p. 245-247°C; FT-IR (KBr, νmax, cm-1): 3150, 3240, 2951,
2253, 1690, 1580, 1070. 1H NMR (CDCl3, 400 MHz): δ 4.4
(s, 1H), 7.1-7.2 (m, 4H), 7.1-7.3 (m, 4H), 8.5 (s, 2H). Elemental
analysis of C19H11N2O3Cl calcd. (found) (%):C, 65.06 (65.10);
H, 3.20 (3.30); N, 7.99 (7.95).
2-Amino-4,5-dihydro-4-(p-tolyl)-5-oxopyrano[3,2-c]-
chromene-3-carbonitrile (3i): Light yellow colour, m.p. 280-
282 ºC; FT-IR (KBr, νmax, cm-1): 3113, 3230, 2935, 2235, 1680,
1560, 1050. 1H NMR (CDCl3, 400 MHz): δ 4.2 (s, 1H), 6.9-
7.1 (m, 4H), 6.4-6.6 (m, 4H), 8.1 (s, 2H). Elemental analysis
of C20H14N2O3 calcd. (found) (%):C, 72.72 (72.70); H, 4.27
(4.30); N, 8.48 (8.50).
2-Amino-4,5-dihydro-4-(4-hydroxyphenyl)-5-oxopyrano-
[3,2-c]chromene-3-carbonitrile (3j): Light yellow color, mp
263-265 ºC. FT-IR (KBr, νmax, cm-1): 3163, 3260, 2965, 2250,
1690, 1540, 1070. 1H NMR (CDCl3, 400 MHz): δ 4.2 (s, 1H),
5.2 (s, 1H), 6.8-6.9 (m, 4H), 6.3-6.5 (m, 4H), 8.2 (s, 2H).
Elemental analysis of C20H14N2O4 calcd. (found) (%):C, 68.67
(68.70); H, 3.64 (3.62); N, 8.43 (8.42).
2-Amino-4,5-dihydro-4-(2,4-dichlorophenyl)-5-oxo-
pyrano[3,2-c]chromene-3-carbonitrile (3k): Light yellow
colour, m.p. 260-262 ºC. FT-IR (KBr, νmax, cm-1): 3140, 3270,
2965, 2273, 1710, 1590, 1060. 1H NMR (CDCl3, 400 MHz): δ
4.7 (s, 1H), 7.2-7.3 (m, 4H), 7.5-7.6 (m, 3H), 8.5 (s, 2H). Elem-
TABLE-2 
SCREENING OF CATALYST CONCENTRATION AND SOLVENTS 
Entry Catalyst concentration (mL) Solvent Condition Time (min) Yield (%) 
1   DCM Reflux 60 Trace 
2   Chloroform Reflux 60 Trace 
3   Acetonitrile Reflux 60 Trace 
4   DMF Reflux 60 Trace 
5   Ethanol Reflux 60 25 
6 0.5 – Reflux 60 60 
7 0.5 – 50 °C 60 65 
8 0.5 – 60 °C 60 70 
9 0.5 – 70 °C 60 72 
10 0.5 – 90 °C 60 78 
11 0.5 DCM Reflux 60 45 
12 0.5 Chloroform Reflux 60 60 
13 0.5 Acetonitrile Reflux 60 55 
14 0.5 DMF Reflux 60 40 
15 0.5 Ethyl alcohol Reflux 60 61 
16 0.1 Ethyl alcohol Reflux 60 35 
17 0.2 Ethyl alcohol Reflux 60 50 
18 0.3 Ethyl alcohol Reflux 60 65 
19 0.4 Ethyl alcohol Reflux 60 78 
20 0.5 Ethyl alcohol Reflux 60 81 
21 0.5 Ethyl alcohol Reflux 60 75 
22 0.5 Ethyl alcohol 30-40 °C 60 85 
23 0.5 Ethyl alcohol 50-60 °C 40 96 
24 0.5 Ethyl alcohol MW 3 95 
 



















































Scheme-II: Mechanism of 3,4-dihydropyrano[c]chromene derivatives
ental analysis of C19H10N2O3Cl2 calcd. (found) (%):C, 59.24
(59.30); H, 2.62 (2.63); N, 7.27 (7.30).
2-Amino-4,5-dihydro-4-(2-methoxyphenyl)-5-oxo-
pyrano[3,2-c]chromene-3-carbonitrile (3l): Light yellow
color, mp 280-282 ºC. FT-IR (KBr, νmax, cm-1): 3113, 3230,
2935, 2235, 1680, 1560, 1050. 1H NMR (CDCl3, 400 MHz): δ
4.2 (s, 1H), 6.9-7.1 (m, 4H), 6.4-6.6 (m, 4H), 8.1 (s, 2H).
Elemental analysis of C20H14N2O4 calcd. (found) (%):C, 69.36
(69.30); H, 4.07 (4.10); N, 8.09 (8.10).
2-Amino-4,5-dihydro-4-(2-chlorophenyl)-5-oxopyrano-
[3,2-c]chromene-3-carbonitrile (3m): Light yellow colour,
m.p. 263-264 ºC. FT-IR (KBr, νmax, cm-1): 3140, 3250, 2951,
2253, 1710, 1570, 1055. 1H NMR (CDCl3, 400 MHz): δ 4.4
(s, 1H), 7.1-7.2 (m, 4H), 7.1-7.3 (m, 4H), 8.5 (s, 2H). Elemental
analysis of C19H11N2O3Cl calcd. (found) (%):C, 65.06 (69.30);
H, 3.16 (3.15); N, 7.99 (7.95).
2-Amino-4,5-dihydro-4-(furan-2-yl)-5-oxopyrano[3,2-
c]chromene-3-carbonitrile (3n): Light yellow colour, m.p.
223-224 ºC. FT-IR (KBr, νmax, cm-1): 3163, 3260, 2965, 2250,
1690, 1540, 1070. 1H NMR (CDCl3, 400 MHz): δ 4.2 (s, 1H),
6.8-6.9 (m, 4H), 6.3-6.5 (m, 4H), 8.2 (s, 2H). Elemental analysis
of C17H10N2O4 calcd. (found) (%):C, 66.67 (66.70); H, 3.29
(3.25); N, 9.15 (9.25).
2-Amino-4,5-dihydro-4-(4-(dimethylamino)phenyl)-5-
oxopyrano[3,2-c]chromene-3-carbonitrile (3o): Light
yellow colour, m.p. 225-226 ºC. FT-IR (KBr, νmax, cm-1): 3213,
3210, 2915, 2243, 1690, 1550, 1040. 1H NMR (CDCl3, 400
MHz): δ 3.2 (s, 6H), 4.4 (s, 1H), 6.8-6.9 (m, 4H), 6.3-6.5 (m,
4H), 8.2 (s, 2H). Elemental analysis of C21H17N3O3 calcd.
(found) (%):C, 70.18 (70.10); H, 4.77 (4.75); N, 11.69 (11.70);
O, 13.36 (13.40).
RESULTS AND DISCUSSION
To set reaction conditions during continuation of present
research work to develop new method, for synthesis of 2-amino-
5-oxo-4,5-dihydropyrano(3,2-c)chromene-3-carbonitrile
derivatives, we followed Multi-component reactions approach.
The reaction conditions were checked under various condi-
tions as illustrated in Tables 1 and 2. The reaction tested in different
solvents, such as chloroform, DCM, acetonitrile, DMF and ethyl
alcohol gave poor yield in absence of catalyst (entry 1 to 5, Table-2)
and we found that in presence of catalyst in solvent-free
conditions and 0.5 mL [Emim]OH catalyst after refluxing at
various temperature resulted into moderate yield i.e. upto 60 to
78 % (entry 6 to 10, Table-2). Further reaction conditions were
checked using 0.5 mL of [Emim]OH and different solvents such
as DCM, chloroform, acetonitrile, DMF, ethanol and found to
give 45, 60, 55, 40, 61 % yield, respectively (entry 11 to 15,
Table-2). To confirm catalyst concentration, reactions were per-
formed at various catalyst concentration using ethyl alcohol as
solvent from 0.1 M, 0.2 M, 0.3 M, 0.4 M and 0.5 M which
resulted into 35, 50, 65, 78, 81 % yield, respectively (entry 16 to
20, Table-2).
In order to set temperature condition, temperature was
increased from room temperature to 60 ºC and with increase
in temperature the yield of products was increased from 81 to 96
% (entry 21 to 23, Table-2). All the reactions were monitored
by thin layer chromatography. Similarly, to check  the efficiency
and practicality of proposed protocol, we used different aromatic
aldehydes and the results are illustrated in Table-3. The reaction
takes place with satisfied yield under microwave conditions
in presence of polar solvents ethyl alcohol, DMF, water, aceto-
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nitrile and methanol. It was observed that ethanol medium is
the best reaction medium among the polar solvents used in
demonstration and reaction proceeded very smoothly which
gave the desired product with excellent yield within short
reaction time (entry 24, Table-2). The aryl aldehydes which
possess electron withdrawing substituent gave high yield as
compared to aromatic aldehydes bearing electron donating
substituent as illustrated in Table-3.
Reaction mechanism: In this reaction, [Emim]OH acts
as the base, malononitrile and 4-hydroxycoumarine undergo
enolization from a to b. The b on cross aldol condensation with
c gave intermediate d. The intermediate d on E1cB elimination
gives intermediate e. The intermediate e with malononitrile
on Michael addition gives intermediate f, which on cyclization
gives intermediate g and after protonation forms intermediate h.
Finally h on rearrangement converted into dihydropyrano[2,3-c]-
chromene (Scheme-II).
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